News | Latest Breaking News Stories & Headlines

Remdesivir is expected to be in high demand as one of the only treatments shown to alter the course of Covid-19

US buys up global supply of Covid-19 drug Remdesivir

The US government has bought virtually the entire production of the Covid-19 drug Remdesivir for the next three months.

Study shows promising results for the use of remdesivir

Anti-viral drug effective against coronavirus - study

Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published last night, three weeks after the US's top infectious diseases expert said the study showed the medication has "clear-cut" benefits.

Coronavirus • 23 May 20

Gillead Sciences CEO Daniel O'Day speaks during a meeting with US President Donald Trump in the Oval Office of the White House

US approves remdesivir for coronavirus patients

The US Food and Drug Administration has granted authorisation to Gilead Sciences for emergency use of its experimental antiviral drug remdesivir to treat patients with Covid-19.

US • 01 May 20

How drugs and vaccines are being designed to fight Covid-19

News about studies into the drug Remdesivir has led bulletins across the world over the last 24 hours. Remdesivir is designed to target a specific process which takes place in a cell infected by the virus that causes Covid-19.

Prime Time • 30 Apr 20

Remdesivir, which is administered intravenously, was among the first drugs suggested as a treatment

Experimental virus drug fails in human trials

The experimental coronavirus treatment remdesivir has failed in its first randomised clinical trial, inadvertently released results have shown, dampening expectations for the closely watched drug.

Coronavirus • 24 Apr 20

A media report detailed encouraging partial data from trials of the US company's experimental drug remdesivir in severe Covid-19 patients

Covid-19 patients respond to Gilead's drug, share surge

Gilead Sciences' shares surged 16% in after hours trading last night after a media report detailing encouraging partial data from trials of the US company's experimental drug remdesivir in severe Covid-19 patients.

Business • 17 Apr 20